Loading…
Acadia Healthcare Company, Inc. is projected to rise to $34.85 by 2027, a +45% move from its current price of $24.09. ACHC is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $23.43 | $24.10 | $24.79 | +0.05% |
| May 30 | $23.17 | $24.11 | $25.09 | +0.09% |
| May 31 | $22.97 | $24.12 | $25.33 | +0.14% |
| Jun 1 | $22.81 | $24.14 | $25.54 | +0.19% |
| Jun 2 | $22.67 | $24.15 | $25.72 | +0.24% |
| Jun 3 | $22.55 | $24.16 | $25.89 | +0.28% |
| Jun 4 | $22.43 | $24.17 | $26.04 | +0.33% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $22.43 | $24.17 | $26.04 | +0.33% |
| Week 2 | $21.82 | $24.25 | $26.95 | +0.66% |
| Week 3 | $21.38 | $24.33 | $27.69 | +1.00% |
| Week 4 | $21.03 | $24.41 | $28.34 | +1.33% |
| Week 5 | $20.73 | $24.49 | $28.94 | +1.67% |
| Week 6 | $20.47 | $24.57 | $29.50 | +2.00% |
| Week 7 | $20.24 | $24.65 | $30.04 | +2.34% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico.
The company owns and operates acute inpatient psychiatric facilities; specialty treatment facilities comprising residential recovery facilities and eating disorder facilities; comprehensive treatment centers; and residential treatment centers, as well as outpatient behavioral healthcare facilities for the behavioral healthcare and recovery needs of communities.
Acadia was founded in 2005 and is headquartered in Franklin, Tennessee.
Acadia Healthcare Company, Inc. trades at $23.18 per share.
Its market capitalization is $2.13B and it ranks 1955.
The forecast shows a path of growth from 2026 onward, with 2026 averaging $23.18 (neutral) and rising thereafter to 2027 averaging $32.95 (Bullish) and higher, culminating in 2050 averaging $251.72 with a max of $478.30 and a bullish stance.
Overall, the long-horizon outlook indicates meaningful upside potential, though these are estimates and not guarantees.
A major floor 51.5% below — a decisive break under it would weaken the trend.
The nearest floor, 4.4% below — buyers have tended to step in here.
The nearest ceiling, 17.3% above — a clean break opens room to run.
A major ceiling 26.0% above — clearing it would confirm fresh momentum.
Key ACHC support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ACHC market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $23.57 | Buy | $23.91 | Buy |
| MA 10 | $24.78 | Sell | $24.42 | Sell |
| MA 20 | $25.44 | Sell | $25.05 | Sell |
| MA 50 | $25.39 | Sell | $24.58 | Sell |
| MA 100 | $21.18 | Buy | $22.93 | Buy |
| MA 200 | $20.66 | Buy | $23.23 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 43.94 | Neutral |
| Stoch RSI (14) | 36.20 | Neutral |
| CCI (20) | -75.14 | Neutral |
| Williams %R (14) | -74.09 | Info |
| MACD (12,26,9) | -0.33 | Sell |
| ROC (12) | -4.33 | Sell |
| Bollinger %B (20,2) | 0.27 | Neutral |
| Stochastic %K (14) | 25.91 | Neutral |
| TRIX (15) | -0.14 | Sell |
| Awesome (5,34) | -2.58 | Sell |
| Ultimate (7,14,28) | 34.39 | Neutral |
| Momentum (10) | -1.93 | Sell |
| Aroon Osc (25) | -64.00 | Sell |
| Hull MA (9) | 22.90 | Buy |
| ADX (14) | 17.39 | Neutral |
| ATR (14) | 0.68 | Info |
The near-term picture is labeled BULLISH in the technical view.
Key near-term levels include RSI(14) at 40, with the 50-day simple moving average at $25.36 and the 200-day simple moving average at $20.61.
Support is seen at $23.02 and resistance at $28.26, framing a 30-day trading range of $19.11 to $28.11. Annualized volatility is 60%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $11.68 | $24.09 | $34.43 | 0% | Neutral | |
| $27.55 | $34.85 | $46.76 | +45% | Bullish | |
| $30.25 | $39.36 | $54.78 | +63% | Bullish | |
| $33.06 | $44.04 | $63.10 | +83% | Bullish | |
| $34.97 | $47.56 | $69.84 | +97% | Bullish | |
| $38.40 | $53.24 | $79.87 | +121% | Bullish | |
| $44.93 | $63.43 | $97.00 | +163% | Bullish | |
| $50.62 | $72.67 | $113.10 | +202% | Bullish | |
| $61.02 | $89.00 | $140.76 | +269% | Bullish | |
| $68.85 | $101.98 | $163.72 | +323% | Bullish | |
| $99.17 | $157.50 | $269.23 | +554% | Bullish | |
| $176.22 | $315.79 | $591.52 | +12.1x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $11.68 | $24.09 | $28.30 | +0.00% |
| June 2026 | $20.59 | $24.20 | $29.13 | +0.46% |
| July 2026 | $21.21 | $25.15 | $30.70 | +3.92% |
| August 2026 | $21.57 | $25.75 | $31.77 | +2.39% |
| September 2026 | $21.08 | $25.31 | $31.49 | -1.73% |
| October 2026 | $21.13 | $25.49 | $31.97 | +0.74% |
| November 2026 | $21.97 | $26.63 | $33.63 | +4.47% |
| December 2026 | $22.25 | $27.09 | $34.43 | +1.70% |
Click any year to see its month-by-month ACHC forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, ACHC is projected to trade between $11.68 and $34.43, averaging $24.09 — a potential gain of 0% from today's $24.09. Price action looks broadly range-bound.
Acadia Healthcare Company, Inc.'s 2027 outlook centres on $34.85, within a $27.55 to $46.76 range. That is up +45% on the projected 2026 average. That marks a +45% change versus current levels. Buyers look set to stay in control over this stretch.
By 2028, ACHC could reach as high as $54.78, with a base case around $39.36 and support toward $30.25 — roughly +63% from $24.09. Momentum favours further upside here.
Expect ACHC to range from $33.06 to $63.10 through 2029. The $44.04 average target implies a +83% move from current prices. That is up +12% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The ACHC price prediction for 2030 points to an average of $47.56 (low $34.97, high $69.84) — a potential gain of +97% on today's $24.09. Momentum favours further upside here.
In 2031, ACHC is projected to trade between $38.40 and $79.87, averaging $53.24 — a potential gain of +121% from today's $24.09. That is up +12% on the projected 2030 average. Buyers look set to stay in control over this stretch.
Acadia Healthcare Company, Inc.'s 2032 outlook centres on $63.43, within a $44.93 to $97.00 range. That is up +19% on the projected 2031 average. That marks a +163% change versus current levels. Momentum favours further upside here.
By 2033, ACHC could reach as high as $113.10, with a base case around $72.67 and support toward $50.62 — roughly +202% from $24.09. Buyers look set to stay in control over this stretch.
Expect ACHC to range from $61.02 to $140.76 through 2034. The $89.00 average target implies a +269% move from current prices. That is up +22% on the projected 2033 average. Momentum favours further upside here.
The ACHC price prediction for 2035 points to an average of $101.98 (low $68.85, high $163.72) — a potential gain of +323% on today's $24.09. Buyers look set to stay in control over this stretch.
In 2040, ACHC is projected to trade between $99.17 and $269.23, averaging $157.50 — a potential gain of +554% from today's $24.09. That is up +54% on the projected 2035 average. Momentum favours further upside here.
Acadia Healthcare Company, Inc.'s 2050 outlook centres on $315.79, within a $176.22 to $591.52 range. That is up +101% on the projected 2040 average. That marks a +12.1x change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in ACHC today (≈ 41.511 ACHC) could be worth
$13,108.96
+$12,108.96 (+1211%) by 2050 · US Dollar
Based on the average projected ACHC price of $315.79 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ACHCwould be worth at today's price.
$1,000 invested in ACHC on May 27, 2025 (≈ 42.517006 ACHC) would be worth
$1,024.23
+$24.23 (+2.4%) today · 1.02× · US Dollar
Based on a ACHC entry price of $23.52 vs. today's $24.09.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $24.07 | $1,000.83 | +0.1% |
| 1 month ago | $28.15 | $855.77 | -14.4% |
| 3 months ago | $22.29 | $1,080.75 | +8.1% |
| 6 months ago | $17.2 | $1,400.58 | +40.1% |
| 1 year ago | $23.52 | $1,024.23 | +2.4% |
| All time (5.0y) ago | $64.6 | $372.91 | -62.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ACHC forecast.
Our base-case forecast reaches $48.00 around 2031.
Implied market cap at $48.00: $4.41B
The multi-year forecast points to sustained upside, with the average price climbing from $23.18 in 2026 to $251.72 in 2050 and bullish sentiment across the horizon.
In 2026 the avg is $23.18 with neutral sentiment and a 0% ROI; from 2027 onward the outlook is bullish, with 2027 avg $32.95 (ROI 42.2%), 2028 avg $36.62 (ROI 58%), 2029 avg $39.89 (ROI 72.1%), and 2030 avg $42.87 (ROI 84.9%).
The forecast continues with 2031 avg $47.23 (ROI 103.8%), 2032 avg $54.70 (ROI 136%), 2033 avg $62.51 (ROI 169.7%), 2034 avg $76.65 (ROI 230.7%), and 2035 avg $86.74 (ROI 274.2%).
By 2040, the avg rises to $129.03 (ROI 456.6%), and by 2050 the avg reaches $251.72 (ROI 986%), with a max of $478.30. The sentiment remains BULLISH throughout.
Tap a question to reveal the answer.
In 2030 the forecasted average price is $42.87, with a min of $31.29 and a max of $63.46, and an anticipated ROI of 84.9% with bullish sentiment.
The long-horizon forecast is bullish from 2027 onward, with rising averages and positive ROI (e.g., 2027 ROI 42.2%, 2030 ROI 84.9%, and 2050 ROI 986%), though these are estimates and not guarantees.
Yes. The 2040 forecast shows an average of $129.03 with a range of $80.06 to $223.25, indicating the possibility of crossing $100 within the forecast window.
Current price is $23.18 and market cap is $2.13B.
Sentiment is BULLISH; RSI(14) is 40. The 50-day SMA is $25.36, the 200-day SMA is $20.61. Support is $23.02 and resistance is $28.26. The 30-day range is $19.11 to $28.11, and annualized volatility is 60%.
Acadia Healthcare Company, Inc. Community Discussion
0Share your Acadia Healthcare Company, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.